Efficacy of Omega-3 Supplementation in Patients with Dry Eyes Disease: An Interventional Study

Efficacy of Omega-3 Supplementation in Patients with Dry Eyes Disease: An Interventional Study - Efficacy of Omega-3 Supplementation in Patients with Dry Eyes Disease: An Interventional Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000059789

Enrollment

Registered

2025-11-15

Start date

2024-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eyes disease

Interventions

Intervention Group (Optimax O3 - Omega-3 Supplementation): Participants in the intervention group will receive Optimax O3 at a dose of 2 capsules once daily for 12 weeks. Each capsule contains EPA 180

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 17-80 years old 2. Diagnosed with dry eyes disease 3. Willing to participate and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Declines to participate in the study 2. Patient with type 2 diabetes mellitus 3. History of ocular surgery (post-operative patients within the past 12 months) 4. current ocular infection

Design outcomes

Primary

Measure	Time frame
Change in the tear film break-up time (TBUT) from baseline to 12 weeks after omega-3 supplementation	—

Secondary

Measure	Time frame
Change in the Ocular Surface Disease Index (OSDI) score from baseline to 12 weeks after omega-3 supplementation	—

Countries

Asia(except Japan)

Contacts

Public ContactLuciana Luciana

School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia Department of Ophthalmology

L.haryady@hotmail.com+6281369726379

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026